Diversified Healthcare Trust Closes $120 Million Mortgage Loan
Diversified Healthcare Trust (Nasdaq: DHC) has secured a $120 million mortgage loan on eight properties in its Medical Office and Life Science Portfolio, covering approximately 725,000 square feet across seven states. The properties have a 93% occupancy rate and a weighted average remaining lease term of 5.4 years. The loan, with a 6.864% fixed interest rate, is non-recourse and interest-only for 10 years, with an implied capitalization rate of 7.2% and a loan-to-value ratio of 50%. DHC plans to use 50% of the proceeds to redeem some of its 9.750% senior notes due 2025 and the rest for capital investments and liquidity improvement. This move is part of DHC's strategy to lower financing costs and extend debt terms.
- DHC secures $120 million in new financing.
- Properties have a high occupancy rate of 93%.
- Weighted average remaining lease term is 5.4 years.
- Interest-only loan with a 6.864% fixed rate for 10 years.
- Implied capitalization rate of 7.2% indicates a solid return.
- Loan-to-value ratio is approximately 50%, suggesting moderate leverage.
- 50% of loan proceeds will redeem high-interest senior notes, reducing future interest expenses.
- Remaining proceeds to be used for capital investments and liquidity improvement.
- Part of a broader financing strategy to lower costs and extend debt terms.
- DHC faces a high interest rate of 6.864% for the loan.
- Occupancy rate, though high, leaves a 7% vacancy that needs to be managed.
- Need to use loan proceeds to redeem 9.750% senior notes indicates existing high-cost debt.
- Properties are spread across seven states, potentially increasing management complexity.
- Weighted average lease term of 5.4 years implies future renewal risks.
Insights
The closing of a
The decision to use approximately
However, while this refinancing approach is prudent, it's important to note the
Lastly, using the remaining proceeds for capital investments and liquidity improvements signals an intent to bolster financial health and potentially drive growth. Investors should watch for how effectively these investments translate into improved operational performance and tenant retention, given the current
This mortgage loan closing indicates strategic positioning within the Medical Office and Life Science Property sector. With a weighted average remaining lease term of 5.4 years and a
The choice of lenders—Wells Fargo, Bank of Montreal and UBS—adds credibility to this financial arrangement. Their participation underscores confidence in DHC's property portfolio and business strategy.
Furthermore, redirecting a portion of the loan to fund capital investments can be a catalyst for future enhancements and upgrades, making properties more attractive to current and potential tenants. This can lead to higher occupancy rates and potentially increased lease terms, boosting long-term revenue streams.
However, stakeholders should remain vigilant about the economic environment's impact on the healthcare real estate sector. Fluctuations in healthcare policies, tenant financial health and broader economic conditions could influence occupancy rates and lease renewals. The firm’s ability to navigate these variables will be important for sustained performance.
The loan is an interest only 10-year mortgage with a
Matt Brown, Chief Financial Officer and Treasurer of DHC, made the following statement.
“Today’s announced financing is the first step in executing on our broader financing strategy to lower financing costs, improve weighted average remaining debt term and enhance our liquidity profile.”
The lenders were Wells Fargo Bank, National Association, Bank of Montreal and UBS AG.
WARNING CONCERNING FORWARD-LOOKING STATEMENTS
This press release contains statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Also, whenever DHC uses words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “will”, “may” and negatives or derivatives of these or similar expressions, DHC is making forward-looking statements. These forward-looking statements are based upon DHC’s present intent, beliefs or expectations, but forward-looking statements are not guaranteed to occur and may not occur. DHC currently intends to use approximately
The information contained in DHC’s filings with the SEC, including under the caption “Risk Factors” in DHC’s periodic reports, or incorporated therein, identifies other important factors that could cause differences from DHC’s forward-looking statements. DHC’s filings with the SEC are available on the SEC’s website at www.sec.gov.
You should not place undue reliance upon forward-looking statements.
Except as required by law, DHC does not intend to update or change any forward-looking statements as a result of new information, future events or otherwise.
About Diversified Healthcare Trust:
DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout
A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq.
No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240530930388/en/
Kevin Brady, Director, Investor Relations
(617) 231-3017
Source: Diversified Healthcare Trust
FAQ
What is the amount of the mortgage loan secured by Diversified Healthcare Trust?
What is the interest rate on Diversified Healthcare Trust's new loan?
What is the occupancy rate of the properties securing the mortgage loan for DHC?
How will DHC use the $120 million mortgage loan proceeds?
What is the duration of the mortgage loan obtained by Diversified Healthcare Trust?
What is the loan-to-value ratio of the mortgage secured by Diversified Healthcare Trust?